Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 54 (12%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (16%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BISOPROLOL | 5MG | TABLET | Resolved | 2020-03-26 | 2020-03-27 | 109422 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2019-02-11 | 2019-03-02 | 75262 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2020-03-26 | 2020-04-03 | 109442 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2023-11-22 | 2024-01-17 | 211081 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2024-02-26 | 2024-03-09 | 220663 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Actual shortage | 2024-04-22 | 2024-04-23 | 225881 |
| TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2019-06-10 | 2019-06-28 | 86053 |
| TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Resolved | 2019-05-06 | 2019-06-08 | 83138 |
| TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Resolved | 2019-11-21 | 2019-11-28 | 99486 |
| CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-04-28 | 2021-05-08 | 138169 |
| CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-09-17 | 2021-12-12 | 145808 |
| CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-09-24 | 2021-12-12 | 146191 |
| CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-03-16 | 2024-03-02 | 187295 |
| ENALAPRIL | 2MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73668 |
| ENALAPRIL | 4MG | TABLET | Resolved | 2018-04-02 | 2018-05-23 | 44405 |
| ENALAPRIL | 4MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73671 |
| ENALAPRIL | 8MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73674 |
| ENALAPRIL | 16MG | TABLET | Resolved | 2018-03-13 | 2018-05-23 | 42549 |
| ENALAPRIL | 16MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73677 |
| ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-06-22 | 2023-09-06 | 196102 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |